亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

X-Ray-Triggered Release of Drugs from Nanoscale Drug Carriers

技術優勢
Nanoparticles can be modified to suit drug Drug delivery can target specific cellular locations Ability to activate release of drug in target cell X-ray triggering method is already common component of clinical procedures Lower systemic toxicity Applicable to wide variety of drugs
技術應用
Targeted delivery of small molecule therapeutics
詳細技術說明
Small molecule chemotherapeutics have been employed in cancer therapy.  However, their effectiveness is often hampered by systemic toxicity.  Although prodrugs have decreased systemic toxicity, they have met with limited success.  External triggering by microwaves, ultrasound, light, and magnetic fields, as well as natural triggering have been explored as a mechanism of drug molecule release, but all fall short due to lack of targeting precision or shallow penetration depths.  Thus, there exists a need for a drug delivery approach that can deliver a prodrug to a target cellular location and controllably release the drug at that target cellular location. Researchers at the University of California, Davis have identified a means by which large quantities of inactive drugs (particularly chemotherapeutics) can be delivered by nanoscale drug carriers to a target location where they can be rendered active by X-rays. Because X-rays are highly penetrating and have been used clinically in diagnosis and treatment of tumors, x-rays can potentially become a successful external triggering tool by cleaving the chemical bonds of the molecules linking the drug molecules to the nanoscale drug carriers for cell-specific delivery. The technology also allows for several variations of the nanosystem that make it amenable to a wide array of delivery targets and drugs.
*Abstract

Researchers at the University of California, Davis have identified a means by which large quantities of inactive drugs (particularly chemotherapeutics) can be delivered by nanoscale drug carriers to a target location where they can be rendered active by X-rays.

*IP Issue Date
Jun 12, 2018
*Principal Investigation

Name: Ting Guo

Department:


Name: Zane Starkewolfe

Department:

申請號碼
9993553
其他

Additional Technologies by these Inventors


Tech ID/UC Case

25582/2013-449-0


Related Cases

2013-449-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備